The clinico-pathologic role of microRNAs miR-9 and miR-151-5p in breast cancer metastasis (Q39630958)

13 September 2017

The clinico-pathologic role of microRNAs miR-9 and miR-151-5p in breast cancer metastasis (English)

1 reference

13 September 2017

1 reference

1 reference

Jonathan Krell

1

1 reference

13 September 2017

Adam E Frampton

2

1 reference

13 September 2017

Jimmy Jacob

3

1 reference

13 September 2017

Loredana Pellegrino

4

1 reference

13 September 2017

Laura Roca-Alonso

5

1 reference

13 September 2017

Daniel Zeloof

6

1 reference

13 September 2017

Costi Alifrangis

7

1 reference

13 September 2017

Jacqueline S Lewis

8

1 reference

13 September 2017

Long R Jiao

9

1 reference

13 September 2017

Justin Stebbing

10

1 reference

13 September 2017

Leandro Castellano

11

1 reference

13 September 2017

1 June 2012

1 reference

Molecular Diagnosis and Therapy

13 September 2017

1 reference

13 September 2017

16

1 reference

13 September 2017

3

1 reference

13 September 2017

167-172

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03262205

13 September 2017

0 references

cites work

Cancer metastasis: building a framework

1 reference

https://api.crossref.org/works/10.1007%2FBF03262205

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262205

The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262205

Micromanagers of malignancy: role of microRNAs in regulating metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262205

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262205

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262205

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262205

MicroRNAs and cancer: short RNAs go a long way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262205

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262205

The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262205

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262205

MicroRNA gene expression deregulation in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262205

Endogenous human microRNAs that suppress breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262205

A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262205

A microRNA DNA methylation signature for human cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262205

Molecular restoration of archived transcriptional profiles by complementary-template reverse-transcription (CT-RT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262205

miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262205

Stromal gene expression predicts clinical outcome in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262205

HER2 testing in the UK: further update to recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262205

mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262205

Circulating tumor cells and plasma DNA analysis in patients with indeterminate early or metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262205

Altered LKB1/CREB-regulated transcription co-activator (CRTC) signaling axis promotes esophageal cancer cell migration and invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262205

ETV6-NTRK3-mediated breast epithelial cell transformation is blocked by targeting the IGF1R signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262205

Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262205

microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03262205

Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications

21 January 2018

1 reference

12 December 2020

Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma

1 reference

12 December 2020

miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis

1 reference

12 December 2020

MicroRNA-151 and its hosting gene FAK (focal adhesion kinase) regulate tumor cell migration and spreading of hepatocellular carcinoma

1 reference

12 December 2020

MicroRNAs--the micro steering wheel of tumour metastases

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03262205

1 reference

13 September 2017

1 reference